Bertrand Rochat (1966) obtained his PhD at the University of Lausanne in Switzerland, following which he carried out post-doctoral research in France, the United States and Scotland. From 2001 to 2003, he worked as lab head in the department of Pre-Clinical Safety at Novartis Pharma in Switzerland. Since 2003, he has been in charge of the Mass Spectrometry Facility at the University Hospital of Lausanne in Switzerland. In that role, Dr. Rochat helps medical doctors and biologists in their research and, in parallel, carries out his own research on • Intratumoral drug metabolism and disposition • Quantitative determination of native peptides by LC-MS in biological matrices • Implementation of a targeted metabolomics analysis in patient plasma. He has published numerous original articles, editorials, and reviews in these fields.